Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Core Scientific (CORZ) Deferred Taxes (2021 - 2022)

Core Scientific has reported Deferred Taxes over the past 2 years, most recently at -$22.0 million for Q4 2022.

Quarterly results put Deferred Taxes at -$22.0 million for Q4 2022, down 470.61% from a year ago — trailing twelve months through Sep 2023 was -$22.0 million (down 334.61% YoY), and the annual figure for FY2022 was -$18.5 million, down 294.38%.
Deferred Taxes reached -$22.0 million in Q4 2022 per CORZ's latest filing, down from $12.0 million in the prior quarter.
Across five years, Deferred Taxes topped out at $34.0 million in Q1 2022 and bottomed at -$42.5 million in Q2 2022.